Switching between semaglutide and tirzepatide in obesity Management: an expert-consensus framework for approximate clinical Efficacy-matched switching doses
Expert opinion on pharmacotherapy · 2026 Oct 29 · Schwartzberg E, Berman E, Shani S et
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 28 20:00 ETSource: Expert opinion on pharmacotherapy
From the source
Read at pubmed.ncbi.nlm.nih.govSwitching between semaglutide and tirzepatide in obesity Management: an expert-consensus framework for approximate clinical Efficacy-matched switching doses
Expert opinion on pharmacotherapy · 2026 Oct 29 · Schwartzberg E, Berman E, Shani S et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42952336/
